Patents by Inventor Patrick Downey

Patrick Downey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TAU-BINDING ANTIBODIES
    Publication number: 20230416350
    Abstract: The present invention relates to Tau-binding antibodies and binding fragments thereof.
    Type: Application
    Filed: June 30, 2023
    Publication date: December 28, 2023
    Inventors: DAVID EDWARD ORMONDE KNIGHT, TERENCE SEWARD BAKER, DAVID JAMES MCMILLAN, ROBERT ANTHONY GRIFFIN, GEORGES MAIRET-COELLO, PATRICK DOWNEY, JEAN-PHILIPPE COURADE
  • TAU-BINDING ANTIBODIES
    Publication number: 20230331833
    Abstract: The present invention relates to Tau-binding antibodies and binding fragments thereof.
    Type: Application
    Filed: June 30, 2023
    Publication date: October 19, 2023
    Inventors: KERRY LOUISE TYSON, TERENCE SEWARD BAKER, GEORGES MAIRET-COELLO, PATRICK DOWNEY, JEAN-PHILIPPE COURADE, DAVID EDWARD ORMONDE KNIGHT
  • Tau-binding antibodies
    Patent number: 11746145
    Abstract: The present invention relates to Tau-binding antibodies and binding fragments thereof.
    Type: Grant
    Filed: December 29, 2020
    Date of Patent: September 5, 2023
    Assignee: UCB BIOPHARMA SRL
    Inventors: Kerry Louise Tyson, Terence Seward Baker, Georges Mairet-Coello, Patrick Downey, Jean-Philippe Courade, David Edward Ormonde Knight
  • Tau-binding antibodies
    Patent number: 11732034
    Abstract: The present invention relates to Tau-binding antibodies and binding fragments thereof.
    Type: Grant
    Filed: December 29, 2020
    Date of Patent: August 22, 2023
    Assignee: UCB BIOPHARMA SRL
    Inventors: David Edward Ormonde Knight, Terence Seward Baker, David James McMillan, Robert Anthony Griffin, Georges Mairet-Coello, Patrick Downey, Jean-Philippe Courade
  • ANTI-ALPHA-SYNUCLEIN ANTIBODIES
    Publication number: 20220340648
    Abstract: The present invention relates to alpha synuclein binding antibodies and fragments thereof capable of binding alpha synuclein as a monomer and in fibrils and preventing alpha synuclein aggregation induced by alpha synuclein fibrils. The antibodies of the present invention are for use in the treatment of alpha synucleinopathies, including Parkinson's disease.
    Type: Application
    Filed: February 28, 2022
    Publication date: October 27, 2022
    Inventors: Patrick DOWNEY, Kerry Louise TYSON, Marco KRIEK, Lorenzo DE LICHTERVELDE, Daniel John LIGHTWOOD, David James MCMILLAN, Peter Charles ELLIOT, Terence Seward BAKER
  • ANTI-ALPHA-SYNUCLEIN ANTIBODIES
    Publication number: 20220220192
    Abstract: The present invention relates to antibodies binding alpha synuclein and fragments thereof capable of binding alpha synuclein as a monomer and in fibrils and preventing alpha synuclein aggregation induced by alpha synuclein fibrils. The antibodies of the present invention are for use in the treatment of alpha synucleinopathies, including Parkinson's disease.
    Type: Application
    Filed: January 26, 2022
    Publication date: July 14, 2022
    Inventors: Ralph ADAMS, Patrick DOWNEY, Terence Seward BAKER, Kerry Louise TYSON, Lorenzo DE LICHTERVELDE, Daniel John LIGHTWOOD, David James MCMILLAN
  • Anti-alpha synuclein antibodies
    Patent number: 11292831
    Abstract: The present invention relates to alpha synuclein binding antibodies and fragments thereof capable of binding alpha synuclein as a monomer and in fibrils and preventing alpha synuclein aggregation induced by alpha synuclein fibrils. The antibodies of the present invention are for use in the treatment of alpha synucleinopathies, including Parkinson's disease.
    Type: Grant
    Filed: December 13, 2018
    Date of Patent: April 5, 2022
    Assignee: UCB BIOPHARMA SRL
    Inventors: Patrick Downey, Kerry Louise Tyson, Marco Kriek, Lorenzo De Lichtervelde, Daniel John Lightwood, David James McMillan, Peter Charles Elliott, Terence Seward Baker
  • Anti-alpha-synuclein antibodies
    Patent number: 11261242
    Abstract: The present invention relates to antibodies binding alpha synuclein and fragments thereof capable of binding alpha synuclein as a monomer and in fibrils and preventing alpha synuclein aggregation induced by alpha synuclein fibrils. The antibodies of the present invention are for use in the treatment of alpha synucleinopathies, including Parkinson's disease.
    Type: Grant
    Filed: December 13, 2018
    Date of Patent: March 1, 2022
    Assignee: UCB BIOPHARMA SRL
    Inventors: Ralph Adams, Patrick Downey, Terence Seward Baker, Kerry Louise Tyson, Lorenzo De Lichtervelde, Daniel John Lightwood, David James McMillan
  • TAU-BINDING ANTIBODIES
    Publication number: 20210139574
    Abstract: The present invention relates to Tau-binding antibodies and binding fragments thereof.
    Type: Application
    Filed: December 29, 2020
    Publication date: May 13, 2021
    Inventors: KERRY LOUISE TYSON, TERENCE SEWARD BAKER, GEORGES MAIRET-COELLO, PATRICK DOWNEY, JEAN-PHILIPPE COURADE, DAVID EDWARD ORMONDE KNIGHT
  • TAU-BINDING ANTIBODIES
    Publication number: 20210115121
    Abstract: The present invention relates to Tau-binding antibodies and binding fragments thereof.
    Type: Application
    Filed: December 29, 2020
    Publication date: April 22, 2021
    Inventors: DAVID EDWARD ORMONDE KNIGHT, TERENCE SEWARD BAKER, DAVID JAMES MCMILLAN, ROBERT ANTHONY GRIFFIN, GEORGES MAIRET-COELLO, PATRICK DOWNEY, JEAN-PHILIPPE COURADE
  • ANTI-ALPHA-SYNUCLEIN ANTIBODIES
    Publication number: 20210107971
    Abstract: The present invention relates to antibodies binding alpha synuclein and fragments thereof capable of binding alpha synuclein as a monomer and in fibrils and preventing alpha synuclein aggregation induced by alpha synuclein fibrils. The antibodies of the present invention are for use in the treatment of alpha synucleinopathies, including Parkinson's disease.
    Type: Application
    Filed: December 13, 2018
    Publication date: April 15, 2021
    Inventors: Ralph ADAMS, Patrick DOWNEY, Terence Seward BAKER, Kerry Louise TYSON, Lorenzo DE LICHTERVELDE, Daniel John LIGHTWOOD, David James MCMILLAN
  • ANTI-ALPHA SYNUCLEIN ANTIBODIES
    Publication number: 20210101964
    Abstract: The present invention relates to alpha synuclein binding antibodies and fragments thereof capable of binding alpha synuclein as a monomer and in fibrils and preventing alpha synuclein aggregation induced by alpha synuclein fibrils. The antibodies of the present invention are for use in the treatment of alpha synucleinopathies, including Parkinson's disease.
    Type: Application
    Filed: December 13, 2018
    Publication date: April 8, 2021
    Inventors: Patrick DOWNEY, Kerry Louise TYSON, Marco KRIEK, Lorenzo DE LICHTERVELDE, Daniel John LIGHTWOOD, David James MCMILLAN, Peter Charles ELLIOTT, Terence Seward BAKER
  • Tau-binding antibodies
    Patent number: 10906966
    Abstract: The present invention relates to Tau-binding antibodies and binding fragments thereof.
    Type: Grant
    Filed: July 1, 2019
    Date of Patent: February 2, 2021
    Assignee: UCB BIOPHARMA SRL
    Inventors: Kerry Louise Tyson, Terence Seward Baker, Georges Mairet-Coello, Patrick Downey, Jean-Philippe Courade, David Edward Ormonde Knight
  • Tau-binding antibodies
    Patent number: 10889640
    Abstract: The present invention relates to Tau-binding antibodies and binding fragments thereof.
    Type: Grant
    Filed: May 13, 2019
    Date of Patent: January 12, 2021
    Assignee: UCB BIOPHARMA SPRL
    Inventors: David Edward Ormonde Knight, Terence Seward Baker, David James McMillan, Robert Anthony Griffin, Georges Mairet-Coello, Patrick Downey, Jean-Philippe Courade
  • TAU-BINDING ANTIBODIES
    Publication number: 20190375829
    Abstract: The present invention relates to Tau-binding antibodies and binding fragments thereof.
    Type: Application
    Filed: July 1, 2019
    Publication date: December 12, 2019
    Inventors: KERRY LOUISE TYSON, TERENCE SEWARD BAKER, GEORGES MAIRET-COELLO, PATRICK DOWNEY, JEAN-PHILIPPE COURADE, DAVID EDWARD ORMONDE KNIGHT
  • TAU-BINDING ANTIBODIES
    Publication number: 20190284267
    Abstract: The present invention relates to Tau-binding antibodies and binding fragments thereof.
    Type: Application
    Filed: May 13, 2019
    Publication date: September 19, 2019
    Inventors: DAVID EDWARD ORMONDE KNIGHT, TERENCE SEWARD BAKER, DAVID JAMES MCMILLAN, ROBERT ANTHONY GRIFFIN, GEORGES MAIRET-COELLO, PATRICK DOWNEY, JEAN-PHILIPPE COURADE
  • Tau-binding antibodies
    Patent number: 10344081
    Abstract: The present invention relates to Tau-binding antibodies and binding fragments thereof.
    Type: Grant
    Filed: July 5, 2016
    Date of Patent: July 9, 2019
    Assignee: UCB BIOPHARMA SPRL
    Inventors: Kerry Louise Tyson, Terence Seward Baker, Georges Mairet-Coello, Patrick Downey, Jean-Philippe Courade, David Edward Ormonde Knight
  • Tau-binding antibodies
    Patent number: 10287343
    Abstract: The present invention relates to Tau-binding antibodies and binding fragments thereof.
    Type: Grant
    Filed: July 5, 2016
    Date of Patent: May 14, 2019
    Assignee: UCB BIOPHARMA SPRL
    Inventors: David Edward Ormonde Knight, Terence Seward Baker, David James McMillan, Robert Anthony Griffin, Georges Mairet-Coello, Patrick Downey, Jean-Philippe Courade
  • TAU-BINDING ANTIBODIES
    Publication number: 20180201666
    Abstract: The present invention relates to Tau-binding antibodies and binding fragments thereof.
    Type: Application
    Filed: July 5, 2016
    Publication date: July 19, 2018
    Inventors: DAVID EDWARD ORMONDE KNIGHT, TERENCE SEWARD BAKER, DAVID JAMES MCMILLAN, ROBERT ANTHONY GRIFFIN, GEORGES MAIRET-COELLO, PATRICK DOWNEY, JEAN-PHILIPPE COURADE
  • TAU-BINDING ANTIBODIES
    Publication number: 20180194832
    Abstract: The present invention relates to Tau-binding antibodies and binding fragments thereof.
    Type: Application
    Filed: July 5, 2016
    Publication date: July 12, 2018
    Inventors: Kerry Louise TYSON, Terence Seward BAKER, Georges MAIRET-COELLO, Patrick DOWNEY, Jean-Philippe COURADE, David Edward Ormonde KNIGHT